Want to see AU:C79 full AI Analyst Report?
Top Page
Chrysos Corp. Ltd.
(Sydney:C79)
Select Model
Select Model
Rating:47Neutral
Price Target:
AU$6.50
▼(-12.16% Downside)
Action:Reiterated
Date:08/19/26
The score is held down primarily by weakened financial performance (2026 revenue decline, sharp deterioration in gross/operating profitability, and persistently negative free cash flow) and an extremely expensive valuation (very high P/E with no dividend yield). Technicals provide partial support with an uptrend and positive MACD, but overbought signals temper the benefit.
Positive Factors
Recurring Service Model
PhotonAssay’s service, usage and support fees can create recurring revenue after deployment, while maintenance and consumables extend customer monetization. This installed-base model can make revenue more durable as utilization grows, reducing reliance on one-time equipment sales over the medium term.
Negative Factors
2026 Revenue Contraction
Revenue growth reversed sharply in 2026, with annual revenue down about 28% after rapid scaling through 2025. A contraction at this stage can slow deployment momentum, reduce operating leverage, and make the timing of customer adoption more important to medium-term financial performance.
Read all positive and negative factors
Positive Factors
Negative Factors
Recurring Service Model
PhotonAssay’s service, usage and support fees can create recurring revenue after deployment, while maintenance and consumables extend customer monetization. This installed-base model can make revenue more durable as utilization grows, reducing reliance on one-time equipment sales over the medium term.
Read all positive factors
Chrysos Corp. Ltd. (C79) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$771.61M
Dividend YieldN/A
Average Volume (3M)263.76K
Price to Earnings (P/E)439.0
Beta (1Y)1.57
Revenue Growth-9.02%
EPS GrowthN/A
CountryAU
Employees236
SectorTechnology
Sector Strength88
IndustrySoftware - Application
Share Statistics
EPS (TTM)0.02
Shares Outstanding116,733,795
10 Day Avg. Volume350,184
30 Day Avg. Volume263,762
Financial Highlights & Ratios
PEG Ratio-3.10
Price to Book (P/B)3.42
Price to Sales (P/S)6094.99
P/FCF Ratio-26.61
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$8.98Price Target Upside21.40% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)0.1
Revenue Forecast (FY)AU$112.30M
Chrysos Corp. Ltd. Business Overview & Revenue Model
Company Description
Chrysos Corporation Limited is dedicated to creating and delivering advanced solutions for the mining industry. Established in 2016 and based in Adelaide, Australia, the company's flagship product is PhotonAssay. This innovative technology enables...
How the Company Makes Money
Chrysos makes money primarily by commercializing its PhotonAssay mineral analysis technology through service-based and equipment-related revenue. Key revenue streams include: (1) recurring fees from PhotonAssay deployments (typically structured as...
Chrysos Corp. Ltd. Financial Statement Overview
Summary
Income Statement
42
Neutral
Balance Sheet
67
Positive
Cash Flow
34
Negative
| Breakdown | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 111.00K | 66.11M | 45.36M | 26.82M | 571.00K |
| Gross Profit | -69.90M | 66.09M | 34.42M | 25.73M | 29.00K |
| EBITDA | -60.92M | 17.34M | 11.68M | 5.09M | 2.16M |
| Net Income | 1.79M | -8.22M | -704.00K | 443.00K | -3.94M |
Balance Sheet | |||||
| Total Assets | 306.47M | 264.31M | 243.26M | 163.41M | 144.09M |
| Cash, Cash Equivalents and Short-Term Investments | 25.89M | 21.52M | 61.07M | 53.36M | 92.10M |
| Total Debt | 64.33M | 25.41M | 6.67M | 14.28M | 8.82M |
| Total Liabilities | 108.79M | 66.01M | 44.99M | 39.18M | 21.77M |
| Stockholders Equity | 197.68M | 198.30M | 198.27M | 124.23M | 122.32M |
Cash Flow | |||||
| Free Cash Flow | -25.42M | -59.89M | -56.23M | -42.61M | -25.67M |
| Operating Cash Flow | 13.55M | 8.83M | 3.63M | 4.65M | 1.41M |
| Investing Cash Flow | -41.01M | -68.72M | -59.86M | -47.26M | -26.98M |
| Financing Cash Flow | 40.61M | 17.28M | 64.30M | 3.54M | 111.52M |
Chrysos Corp. Ltd. Technical Analysis
Negative
7.40
Price Trends
6.92
Negative
6.47
Positive
6.97
Negative
Market Momentum
0.05
Positive
42.97
Neutral
37.97
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:C79, the sentiment is Negative. The current price of 7.4 is above the 20-day moving average (MA) of 6.94, above the 50-day MA of 6.92, and above the 200-day MA of 6.97, indicating a bearish trend. The MACD of 0.05 indicates Positive momentum. The RSI at 42.97 is Neutral, neither overbought nor oversold. The STOCH value of 37.97 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:C79.
Chrysos Corp. Ltd. Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | AU$642.42M | 37.07 | 5.34% | ― | 18.83% | ― | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
54 Neutral | AU$29.92M | -10.29 | -18.57% | ― | 12.29% | 55.78% | |
47 Neutral | AU$771.61M | 438.96 | 0.90% | ― | -9.02% | ― | |
46 Neutral | AU$9.15M | -11.67 | -22.87% | ― | 22.37% | 73.68% | |
43 Neutral | AU$35.45M | -4.05 | -23.77% | ― | 10.62% | 36.67% | |
42 Neutral | AU$22.10M | -9.31 | 67.50% | ― | -23.57% | -38.10% |
* Technology Sector Average
AU:C79
Chrysos Corp. Ltd.
6.61
-1.49
-18.40%
AU:3DP
Pointerra
0.03
-0.02
-42.55%
AU:AMX
Aerometrex Ltd.
0.32
0.05
18.87%
AU:VR1
Vection Technologies Ltd.
0.02
-0.03
-69.39%
AU:1CG
UUV Aquabotix Ltd.
0.01
0.00
0.00%
AU:NXL
Nuix Ltd.
1.87
-0.56
-23.05%
Chrysos Corp. Ltd. Corporate Events
Chrysos outlines gold analysis strategy and risk caveats at Mining Forum Americas
Sep 28, 2026
Chrysos Corporation used a presentation at the Mining Forum Americas in Colorado Springs to outline its current activities and positioning in gold analysis technology. Aimed at a professional analyst audience, the material emphasizes that the info...
Chrysos Corporation Seeks ASX Quotation for 130,000 New Shares
Sep 18, 2026
Chrysos Corporation Limited has applied for quotation on the ASX of 130,000 new ordinary fully paid shares, to be issued under its ticker C79. The additional securities, dated 18 September 2026, modestly expand the company’s listed share bas...
Chrysos Director Robert Adamson Exercises Options to Lift Shareholding
Sep 4, 2026
Chrysos Corporation director Robert Henry Richard Adamson has increased his direct shareholding by exercising 25,000 options at an aggregate cost of $112,500, converting them into fully paid ordinary shares. Following the transaction, Adamson now ...
Chrysos Seeks ASX Quotation for Additional 72,500 Shares
Sep 4, 2026
Chrysos Corporation Limited has applied for quotation of 72,500 ordinary fully paid shares on the ASX, with an issue date of September 3, 2026. The new securities increase the company’s listed share capital, reflecting ongoing capital manage...
Yarra Capital Group Exits Substantial Holding in Chrysos Corporation
Aug 31, 2026
Yarra Capital Management and related entities have disclosed that they have ceased to be substantial shareholders in Chrysos Corporation Limited. The group sold 13,471 voting securities between 20 August and 27 August 2026, reducing their holding ...
Chrysos Director Kerry Gleeson Increases Shareholding Through Option Exercise
Aug 25, 2026
Chrysos Corporation Limited, a mining technology company listed on the ASX, is subject to strict disclosure obligations regarding directors’ dealings in its securities. These requirements aim to maintain market integrity and give shareholder...
Chrysos Seeks ASX Quotation for Additional 20,000 Shares
Aug 25, 2026
Chrysos Corporation Limited has applied for quotation of 20,000 new ordinary fully paid shares on the ASX, with an issue date of August 21, 2026. The modest increase in quoted securities slightly expands the company’s equity base and could s...
Yarra Group Takes 5% Substantial Stake in Chrysos Corporation
Aug 21, 2026
A consortium of Yarra entities, led by Yarra Capital Management Limited and Yarra Funds Management Limited, has emerged as a substantial shareholder in Chrysos Corporation Limited with a 5.01% stake, equivalent to 5,834,672 ordinary fully paid sha...
UBS Group AG exits substantial holder position in Chrysos Corporation
Aug 18, 2026
UBS Group AG and its related bodies corporate have notified Chrysos Corporation Limited that they have ceased to be a substantial shareholder as of 14 August 2026. The change follows earlier disclosures in late July and indicates that UBS has redu...
Yarra Capital Group Exits Substantial Holding in Chrysos Corporation
Aug 14, 2026
Yarra Capital Management Limited and associated entities have ceased to be substantial shareholders in Chrysos Corporation Limited after a series of share sales concluded on 12 August 2026. The group collectively disposed of 106,947 Chrysos shares...
Chrysos posts record earnings as PhotonAssay uptake surges
Aug 10, 2026
Chrysos Corporation reported record FY26 results as rising global adoption of its PhotonAssayTM technology lifted revenue 33% to $88.1 million and EBITDA 68% to $27.2 million, expanding its EBITDA margin to 31%. The company processed a record 11.3...
Chrysos Flags Caveats Around FY26 Results and Gold Analysis Focus
Aug 10, 2026
Chrysos Corporation has released its FY26 financial results presentation, outlining its current activities and highlighting its core offering of accelerated, high-precision gold analysis technology. Aimed at a professional analyst audience, the ma...
Chrysos Corporation Positions FY26 Strategy for Global Growth
Aug 10, 2026
Chrysos Corporation’s FY26 annual report presents the company as positioned for growth, highlighting its global footprint, operational overview and a strategic journey built around milestones and evolving business models. The document outlin...
Chrysos swings to profit as PhotonAssay revenue surges
Aug 10, 2026
Chrysos Corporation Limited, a mining technology specialist, derives almost all of its revenue from PhotonAssay™ leases used in mineral assay, complemented by modest consumables sales and other income. Its core PhotonAssay™ offering pr...
Chrysos outlines governance and diversity framework
Aug 10, 2026
Chrysos Corporation Ltd has detailed its corporate governance framework, confirming full compliance with key principles on board oversight, director appointments and performance evaluation. The company maintains a formal Board Charter, written agr...
Chrysos Lodges 2026 Corporate Governance Statement and Appendix 4G
Aug 10, 2026
Chrysos Corporation Limited has lodged its corporate governance statement for the financial year ended 30 June 2026, making it available via its website in accordance with ASX Listing Rule 4.10.3. The statement, current as of 10 August 2026 and ap...
Chrysos Director’s Performance Rights Cut Following Equity Plan Adjustment
Aug 10, 2026
Chrysos Corporation Limited has reported a change in the interests of director Dirk Moore Treasure, reflecting an adjustment in his equity-based remuneration. The disclosure, lodged with the ASX, shows that Treasure retains substantial holdings in...
Chrysos Corrects Director Gregory Holt’s Recorded Shareholding
Aug 10, 2026
Chrysos Corporation Limited has disclosed a minor correction to the indirect shareholding of director Gregory Vincent Holt, held through the G.V. Holt Family Trust. Holt controls the voting rights of shares owned by Holt Family Investments (VIC) P...
Chrysos sets date for FY26 results and investor briefing
Jul 28, 2026
Chrysos Corporation Ltd. has scheduled the release of its full-year financial results for the year ended 30 June 2026 on 11 August 2026. Following the announcement, the company’s Managing Director and CEO, Dirk Treasure, and CFO, Brett Coven...
Chrysos Corrects Director Robert Adamson’s Reported Shareholding
Jul 3, 2026
Chrysos Corporation Limited has disclosed a change in director Robert Adamson’s relevant interests in the company’s securities, primarily reflecting a correction to his previously reported final shareholding. Following the adjustment, ...
Chrysos Chair Sells Shares to Cover Tax Liability, Retains Major Stake
Jul 2, 2026
Chrysos Corporation has disclosed that its chairman, Robert Adamson, sold 529,020 ordinary shares in the company to meet a personal tax liability linked to a previously reported restructuring of his shareholding arrangements. Following the transac...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.